Wednesday, July 8, 2026

biotech · Fabry Disease · Bioequivalence · PLX

Protalix Biotherapeutics

News and analysis for Protalix Biotherapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

2 Snunit St., Science Park, POB 455, Carmiel, 2161401, IL, HACKENSACK, NJ, USA HQ
1994 Founded
197 Employees
Public company Type
PLX · NYSE Ticker
Company details
Status
Public
HQ
2 Snunit St., Science Park, POB 455, Carmiel, 2161401, IL, HACKENSACK, NJ, USA
Founded
1994
Employees
197
Programs
21
Drugs
14
Patents
22
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Protalix Biotherapeutics — regulatory, clinical, and market coverage.

News and analysis for Protalix Biotherapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Protalix Biotherapeutics yet.

Back to company overview →